FNY Managed Accounts’s Synergy Pharmaceuticals, Inc Common Stock SGYP Stock Holding History
Bought
Maintained
Sold
Other funds holding SGYP
NCM
HP
CH
FNY Managed Accounts's SGYP Position: Q1 2018 in Review
FNY Managed Accounts held its Synergy Pharmaceuticals, Inc Common Stock (SGYP) position steady in Q1 2018 at 1,000 shares worth $1K. The position accounts for ﹤0.01% of the portfolio, ranked #574.
FNY Managed Accounts first reported a position in SGYP in Q1 2015 and has held it in 4 quarters since. The position peaked at $18K in Q3 2017. 147 funds tracked by Wall St. Rank hold SGYP as of Q1 2018.
- FNY Managed Accounts held 1,000 shares of Synergy Pharmaceuticals, Inc Common Stock worth $1K as of Q1 2018.
- FNY Managed Accounts left its Synergy Pharmaceuticals, Inc Common Stock share count unchanged in Q1 2018.
- Synergy Pharmaceuticals, Inc Common Stock made up ﹤0.01% of FNY Managed Accounts's portfolio in Q1 2018, its #574 holding.
- FNY Managed Accounts first reported a position in Synergy Pharmaceuticals, Inc Common Stock in Q1 2015 and has held it in 4 quarters since.
- FNY Managed Accounts's Synergy Pharmaceuticals, Inc Common Stock position peaked at $18K in Q3 2017.
- 147 funds tracked by Wall St. Rank held Synergy Pharmaceuticals, Inc Common Stock as of Q1 2018.
Based on FNY Managed Accounts's 13F filing for Q1 2018, filed 18 Apr 2018.